TY - JOUR
T1 - Do microbes play a role in Alzheimer's disease?
AU - Williams, Zoë A. P.
AU - Lang, Leonie
AU - Nicolas, Sarah
AU - Clarke, Gerard
AU - Cryan, John
AU - Vauzour, David
AU - Nolan, Yvonne M.
PY - 2024/4
Y1 - 2024/4
N2 - Alzheimer's disease is a complex and progressive condition that affects essential neurological functions such as memory and reasoning. In the brain, neuronal loss, synaptic dysfunction, proteinopathy, neurofibrillary tangles, and neuroinflammation are the hallmarks of Alzheimer's disease pathophysiology. In addition, recent evidence has highlighted that microbes, whether commensal or pathogenic, also have the ability to interact with their host and to regulate its immune system, therefore participating in the exchanges that lead to peripheral inflammation and neuropathology. Because of this intimate relationship, bacteria, viruses, fungi, and protozoa have been implicated in the development of Alzheimer's disease. Here, we bring together current and most recent evidence of the role of microbes in Alzheimer's disease, raising burning questions that need to be addressed to guide therapeutic approaches and potential prophylactic strategies.
AB - Alzheimer's disease is a complex and progressive condition that affects essential neurological functions such as memory and reasoning. In the brain, neuronal loss, synaptic dysfunction, proteinopathy, neurofibrillary tangles, and neuroinflammation are the hallmarks of Alzheimer's disease pathophysiology. In addition, recent evidence has highlighted that microbes, whether commensal or pathogenic, also have the ability to interact with their host and to regulate its immune system, therefore participating in the exchanges that lead to peripheral inflammation and neuropathology. Because of this intimate relationship, bacteria, viruses, fungi, and protozoa have been implicated in the development of Alzheimer's disease. Here, we bring together current and most recent evidence of the role of microbes in Alzheimer's disease, raising burning questions that need to be addressed to guide therapeutic approaches and potential prophylactic strategies.
UR - http://www.scopus.com/inward/record.url?scp=85190137635&partnerID=8YFLogxK
U2 - 10.1111/1751-7915.14462
DO - 10.1111/1751-7915.14462
M3 - Review article
VL - 17
JO - Microbial Biotechnology
JF - Microbial Biotechnology
SN - 1751-7915
IS - 4
M1 - e14462
ER -